High-Cost Imaging Follow-Ups? Don’t Blame the Radiologist

Article

Radiologists order just 5.3 percent of high-cost imaging examinations, according to a study published online on Nov. 14 in the journal Radiology.

Radiologists order just 5.3 percent of high-cost imaging examinations, according to a study published online this week in the journal Radiology.

Susanna I. Lee, MD, PhD, of Massachusetts General Hospital, and colleagues sought to quantify the source of high-cost scans and understand what sort of examinations these scans involved. They considered chest and abdominal CT, brain and lumbar spine magnetic resonance imaging, and body positron emission tomography from a database of all radiology examinations (approximately 200,000) at Mass General over a six-month period.

Just 1,558 of 29,232 (5.3 percent) of high-cost examinations followed a radiologist’s recommendation, Lee and colleagues found. Chest CT was the high-cost examination most often resulting from a radiologist’s recommendation (9.4 percent), followed by abdominal CT (3.8 percent) and brain MR imaging (3.4 percent).

The examination types with the highest numbers of follow-up examinations were chest radiography, chest CT, abdominal CT, and abdominal ultrasonography. The most common findings resulting in follow-up were pulmonary nodules or masses (found in 35.9 percent of recommended high-cost examinations), other pulmonary abnormalities (9.6 percent), enlarged lymph nodes (6.6 percent), renal lesions (6.5 percent), and negative examination findings (6.5 percent).

Recent Videos
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2025 MJH Life Sciences

All rights reserved.